Myeloproliferative virus, derived from Moloney sarcoma virus, causes erythroleukemia and myeloid leukemia in adult mice. This virus is also capable of fibroblast transfornation in vitro. The virus consists of two separable biological entities which have been cloned. The helper virus component caused no visible changes in adult mice, whereas the defective virus induced both spleen focus formation and a large increase in erythroid precursor cells but retained the sarcoma virus property of transforming fibroblasts in vitro. Thus, myeloproliferative virus is the first murine sarcoma virus which induces erythroleukemia in adult animals.
The availability of RNA tumor viruses which have specific effects on the differentiation of normal cells has stimulated considerably research in this area. Although in avian systems a number of defective leukemia virus strains have been shown to transform both fibroblasts and hematopoietic cells (13, 14, 24) , only Abelson murine leukemia virus transforms both fibroblasts and lymphatic B cells (23, 26) . Kirsten and Harvey murine sarcoma viruses (MSV-Kirsten and MSV-Harvey, respectively) induce erythroid proliferation of spleen cells only in newborn mice (2, 25 ; this paper), and these erythroid cells cannot be transplanted and do not grow as permanent cell lines (unpublished observations). Rauscher and Friend viruses are of particular interest since they induce spleen foci and erythropoiesis in adult Fv-26/2' mice (9, 22, 27) . A few of the erythroid tumor cells produced in the course of the erythroleukemia elicited by these viruses are transplantable and can then be used to establish permanent cell lines (5, 6, 10, 11, 18 Paetz, C. Jasmin, F. Smadja-Joffe, M. C. Le Bousse, and B. Klein, manuscript in preparation). In addition, MPV(MSV) transforms fibroblasts in vitro, a property which can be used to generate mutants which are temperature sensitive for the fibroblast transformation or erythropoiesis-stimulating properties or both. Fibroblast and erythroid transformations (spleen focus formation) are both properties of the same defective viral subunit of the MPV(MSV) complex.
MATERIALS AND METHODS
Cell culture and viruses. All cell lines were grown in modified Eagle medium supplemented with 10% fetal calf serum (18) . Infectious virus was obtained from spleens and tissue culture supernatants as described previously (19) . Unless otherwise stated, the virus was used unconcentrated. Concentrated virus was used in some of the experiments in Table 1 (21) . F4-6 cells can be treated with dimethyl sulfoxide (Me2SO) to induce a 120-fold increase in the SFFV titer as described previously (19) .
Reverse transcriptase assays. Reverse transcriptase activity was calculated as described previously (21) and corrected for variations in the assay by using a standard viral supernatant of Friend F4-6 cells (21) which was kept frozen at -80°C in aliquots.
Spleen focus formation. Spleen focus formation was assayed by injecting Gelman Acrodisc-filtered viral supernatants into the tail vein of mice as indicated in Tables 1 to 3 . Serial 1:5 dilutions were made, and six mice were injected with 0.5-ml viral suspensions for each concentration of the virus. With SFFV, spleen foci were detected 10 days after injection, whereas MPV(MSV)-induced foci were detectable and counted after 16 days.
Focus-forming assay. The fibroblast focus-forming unit (FFU) assay was performed as described previously with NRK fibroblasts (3) .
CFU-E and BFU-E assays. The procedure followed for CFU-E and BFU-E assays was essentially that described by Iscove and Sieber (12) .
Spectrin assays. The assay for spectrin, using spectrin antisera, has been described previously (7) . 9 days (one or two medium changes) in 1% Me2SO containing low-serum medium. Foci were then counted in all wells. The supernatant of cells of all wells after growth in T flasks was also assayed for reverse transcriptase activity. The titer of the original MPV(MSV) was 4 x 104 fibroblast FFU per ml of spleen cell supernatant ( Table 1 ). The titer estimate of fibroblast-transforming particles was strictly proportional to the dose ( Fig. 1) . At endpoint dilution, 3 of 12 wells each contained 1 focus of transformed fibroblasts (Fig. 2) . These cells were kept in 1% Me2SO-5% serum-containing medium, with three medium changes per week for 4 weeks, and then transferred. Only transformed fibroblastic cells survived in two of the three wells which originally contained 1 focus of transformed cells. These cells and all of the cell clones derived from these were virus negative by reverse transcriptase assays ( Table  1 ). The plating of helper virus as assayed by reverse transcriptase activity also followed a single-hit kinetics (Fig. 1) . We can calculate the relative biological titer of both viruses if we assume that the helper virus and the sarcoma virus were equally efficient in infection of rat NRK cells: the titer for the helper virus was oneeighth that of the sarcoma component ( Fig. 1) , that is, 5 x 103/ml. This titer may be a 100-fold underestimate of the titer if measured in murine fibroblasts (15) .
RESULTS

Properties of uncloned MPV(MSV
Fibroblast focus formation in murine SC1 celis was not much higher than that in rat NRK celis. We measured the focus formation of the MPV(MSV) clonal isolate of cell line 6-6#3 infected with LLV-F to estimate the relative titers of the fibroblast-transforming viral component in rat and murine fibroblasts. With one particular cell supernatant, we obtained 1.03 x 104 FFU/ml in NRK cells and 2.9 x 104 FFU/ml in murine SC1 cells, using a similar cell number of rat and mouse cells per well during infection.
The sarcoma virus component is responsible for the spleen focus-forming activity of MPV(MSV). MPV(MSV) injected into the lateral tail vein of adult DBA/2J or C3H/HeJ mice induced visible spleen foci within 12 to 16 days. These foci were distinct and grossly similar in appearance to those caused by Friend SFFV (Tables 1 and 3 ). NRK cells transformed by MPV(MSV) at endpoint dilution were cloned in agar. Four cloned cell lines of two different foci at endpoint dilution were used for the experiments described ( Fig. 2 and Table 1 ). All of these cell clones were reverse transcriptase negative and were also shown to be virus negative by electron microscope observation. All four cell clones could be superinfected by either cloned LLV-F or cloned LLV-Mol (8) ( Table 1 ). All three transformed cell clones released fibroblasttransforming virus on superinfection (Table 1) . The rescued transforming virus of the four cloned sarcoma cell lines, when either cloned LLV-F or LLV-Mol (l.lA) was used for rescue, was able to induce spleen foci after intravenous injection of the virus into adult Fv-2'/28 DBA/ 2J mice ( Table 1 The transforming virus of two of the sarcoma clones rescued by LLV-F was used again for MPV(MSV) cloning. At endpoint dilution, 6 of 24 wells [using the same dilution of MPV(MSV)] contained 1 sarcoma focus and another well contained 2 sarcoma foci if the rescued virus complex of nonproducer cell clone MPV 6-1#5 was used. All of the supernatants of the cells in the wells at endpoint dilution of MSV were negative in the reverse transcriptase assay. The cells of these foci were again cloned in agar. All of these clones were reverse transcriptase negative as expected (Table 2) . MPV(MSV) of cell clone 6-1#5 is thus in excess compared with LLV-F. Cells of clone MPV 6-1#11 were also superinfected with LLV-F, and the sarcoma component was cloned at endpoint dilution (Fig.  2) . MPV(MSV)-transformed fibroblasts of wells each with 1 focus were again cloned in agar.
Some of these cell clones released virus; i.e., they (Fig. 2) showed that the rescued virus and not LLV-F was the SFFV ( p5-1+F (2) p5-2+F (2) p5-3+F (2) p5-5+F (2) p5-8
p5-14 p5-20
p5-8#20 p5-8#1+F (2) p5-8#20+4-3 (2, 10) p5-14#19 p5-14#16 p5-14#19+F (2) p5-14#16+4-3 (10) p5-20#20 We also decided to test cells of wells which did not contain fibroblast foci of transformed cells to exclude the already unlikely possibility that we had copurified a second defective viral putative SFFV subunit of the MPV(MSV) complex which may have been in excess to the MSV subunit. The viral supernatant was further concentrated to detect minute amounts of contaminating virus. None of these supernatants transformed fibroblasts and spleen cells of adult mice. The sarcoma-transforming and spleen focusforming properties should therefore reside in the same viral RNA subunit.
The helper virus of the MPV(MSV) complex is not responsible for spleen focus formation. We wished to exclude the possibility that both helper and transforming viruses of the MPV(MSV) complex are spleen focus forming. Therefore, we looked at the property of the original helper virus of the first cloning experiment at endpoint dilution of the reverse transcriptase activity. We obtained a cell line, NRK 4-3, from one of the reverse transcriptase-positive wells after serial passage which did not contain any transformed fibroblasts (Fig. 2) . The reverse transcriptase-positive supernatant of this cell line ( Spleen and bone marrow cells of mice infected with uncloned and cloned MPV(MSV) were cloned in methylcellulose as described by Iscove and Sieber (12) with and without erythropoietin. None of the cultures showed a large increase in CFU-E or BFU-E in the absence of erythropoietin (Table 4) . However, when a low dose of erythropoietin (0.15 U/ml) was added to MPVinfected spleen cells, we obtained a more than 100-fold increase in BFU-E and an up to 10-fold increase in CFU-E cells compared with cells of control spleens. This increase was even higher MPV(MSV) IN ADULT MICE 579 when a correction was made for the 10-to 20-fold size increase of the spleen in MPV(MSV)-infected mice. The erythroid bursts (BFU-E) caused by MPV(MSV) infection in mouse spleens did not differ in appearance from normal 10-day BFU-E except that they were usually even larger. There was only an increase in BFU-E cells but no increase in CFU-E cells when we assayed for colony formation in vitro with bone marrow cells of MPV(MSV)-infected mice (Table 4). This correlates with the hematological changes which are observed during MPV(MSV) injection of mice (LeBousse-Kerdiles et al., in press; see below). The number of BFU-E cells which were detected in MPV(MSV)-infected mice with a low dose of erythropoietin was approximately the same as that found in normal mice with a high dose of erythropoietin (2 U/ ml) (Table 4) . However, the number of BFU-E cells per infected mouse was at least 10-to 20-fold larger per spleen when a correction was made for the increase in spleen size. A detailed analysis of the type of erythroid cell which is stimulated by MPV(MSV) and its response to erythropoietin will be published elsewhere. Staining with spectrin antiserum of both spleen and bone marrow cells of mice infected with uncloned and cloned MPV(MSV) of cell line MPV 6-6#3+F (Fig. 2) showed a marked increase in the proportion of spectrin-positive cells, whereas the number of benzidine-staining cells was decreased. Spleen and bone marrow cells of mice in the terminal phase of the disease (4 weeks after injection of the virus) were used for the spectrin assay. A total of 56% of the MPV 6-6#3-infected spleen cells and 60% of the bone marrow cells contained spectrin. Only 6% of the spleen cells and 20% of the bone marrow cells of control DBA/2J mice were spectrin positive. The presence of spectrin is an indicator of the presence of both early and late erythroid cells and not of any other differentiated cell (7) . Most of the bone marrow and spleen cells of mice infected with MPV(MSV) are thus erythroid.
DISCUSSION
Our data on the MPV(MSV) virus complex show the following: (i) MPV(MSV) consists of at least two viral species, a replication-competent helper virus and a defective transforming virus; (ii) the helper component does not cause Table 1 and Fig. 2 The cloning procedure that we used employs rat NRK cells. These are known to replicate murine viruses rather inefficiently. Spleen focus fonnation and fibroblast-transforming properties, if dependent on two separate genomic entities, may also have been obtained if the putative separate SFFV entity had been in large excess to the MSV entity or if it had infected rat NRK cells preferentially as compared with the MSV particles. This possibility is extremely improbable because of the following reasons. (i) No SFFV properties were found with cell line NRK 4-3 which, during the first virus cloning, replicated helper virus but did not contain MSV properties at a 25-fold-higher concentration of plating virus than that used for endpoint dilution of the MSV particles which transform NRK cells. (ii) All independently cloned MSV particles of the MPV(MSV) complex also had the properties of spleen focus formation in adult mice. We listed nine of those clones in Fig. 2 and Tables 1 and 2 . We also cloned the sarcoma virus of MPV 6-6#3 (Fig. 2) twice and recloned this virus a third time. All independent clones which have been checked transformed fibroblasts and formed foci in spleens of adult mice (data not shown). (iii) We would have expected to also obtain some SFFV activity by rescue of cells derived from sister wells to wells with transformed fibroblasts if the putative separate SFFV entity had been in excess to MSV. We therefore infected cell lines obtained from sister wells which contained no foci (cell lines p5-2, p5-3, and p5-5) with LLV-F. Efficient replication was monitored by measuring the reverse transcriptase activity of these supernatants. These were further concentrated 50-to 200-fold to obtain maximum detectability of SFFV acitivity in mice. None was detected in any of the four supernatants. (iv) Focus formation in rat fibroblast NRK and murine SC1 cells is similarly efficient. Statistical reasons thus make it extremely unlikely that spleen focus formation and fibroblast transformation are caused by different viral genomes of the MPV(MSV) complex.
The only way to explain our data (MSV and SFFV properties) on a two-virus genome basis would thus be to assume that the putative separate genomes of MPV(MSV) and of a new type of SFFV would, in fact, always be linked as a functional unit similar to the situation found with balanced lethal genes in Drosophila melanogaster, for example. This model can possibly be excluded by generating temperature-sensitive mutants for the fibroblast-transforming property of the virus. It can also be tested by an analysis of the genomic subunits.
The isolation and characterization of MPV(MSV) has shown that an MSV-Mol has been modified, presumably by a recombination event or mutation within the genome. This represents the first case of a modified sarcoma virus causing erythroleukemia in adult mice. Nucleic hybridization data have indicated that although all or part of the sarcoma genome is retained, other new virus sequences have been added to the MPV(MSV) genome. These do not appear to be in the Friend SFFV genome (Pragnell et al., manuscript in preparation).
A histological and hematological study of the disease induced by the cloned virus is necessary to determine whether this isolate can induce the same complex disease as can the uncloned virus. The property of MPV(MSV) to transform fibroblast cells will permit the selection of temperature-sensitive mutants of MPV(MSV) for the fibroblast-transforming gene as described for diverse avian sarcoma viruses (29) . This may give some insight into the mechanism of action of the virus on spleen focus formation and the stimulation (transformation) of erythroid precursor cells.
MPV(MSV)-transformed spleen cells form transplantable tumors (unpublished data). Hematopoietic stem cells from MPV(MSV)-infected mice are serially transplantable in irradiated mice. These observations indicate that it may be possible to isolate hematopoietic cell lines transformed with temperature-sensitive mutants of MPV(MSV). These cell lines could be used to study differentiation of granulocytic and erythroid murine cells in vitro at permissive and nonpermissive temperature. 
